DE69823665D1 - Heterocyclische verbindungen als faktor xa inhibitoren - Google Patents
Heterocyclische verbindungen als faktor xa inhibitorenInfo
- Publication number
- DE69823665D1 DE69823665D1 DE69823665T DE69823665T DE69823665D1 DE 69823665 D1 DE69823665 D1 DE 69823665D1 DE 69823665 T DE69823665 T DE 69823665T DE 69823665 T DE69823665 T DE 69823665T DE 69823665 D1 DE69823665 D1 DE 69823665D1
- Authority
- DE
- Germany
- Prior art keywords
- inhibitors
- factor
- heterocyclic compounds
- relates
- antithrombotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/18—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/08—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9715894.3A GB9715894D0 (en) | 1997-07-29 | 1997-07-29 | Heterocyclic derivatives |
GB9715894 | 1997-07-29 | ||
PCT/GB1998/002210 WO1999006371A1 (en) | 1997-07-29 | 1998-07-23 | Heterocyclic derivatives which inhibit factor xa |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69823665D1 true DE69823665D1 (de) | 2004-06-09 |
DE69823665T2 DE69823665T2 (de) | 2005-04-28 |
Family
ID=10816578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69823665T Expired - Lifetime DE69823665T2 (de) | 1997-07-29 | 1998-07-23 | Heterocyclische verbindungen als faktor xa inhibitoren |
Country Status (23)
Country | Link |
---|---|
US (2) | US6458793B1 (de) |
EP (2) | EP1000033B1 (de) |
JP (1) | JP2001512103A (de) |
KR (1) | KR20010022108A (de) |
CN (1) | CN1265098A (de) |
AT (1) | ATE266007T1 (de) |
AU (1) | AU754747B2 (de) |
BR (1) | BR9811055A (de) |
CA (1) | CA2295945A1 (de) |
DE (1) | DE69823665T2 (de) |
DK (1) | DK1000033T3 (de) |
ES (1) | ES2219894T3 (de) |
GB (1) | GB9715894D0 (de) |
HU (1) | HUP0002528A3 (de) |
IL (1) | IL133516A0 (de) |
NO (2) | NO317419B1 (de) |
NZ (1) | NZ501778A (de) |
PL (1) | PL338355A1 (de) |
PT (1) | PT1000033E (de) |
RU (1) | RU2225404C2 (de) |
SK (1) | SK1272000A3 (de) |
TR (1) | TR200000223T2 (de) |
WO (1) | WO1999006371A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
GB9602166D0 (en) * | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
ZA99607B (en) | 1998-01-27 | 1999-07-27 | Rhone Poulenc Rorer Pharma | Substituted oxoazaheterocyclyl factor xa inhibitors. |
PT1082321E (pt) | 1998-05-02 | 2005-03-31 | Astrazeneca Ab | Derivados heterociclicos que inibem o factor xa |
GB9809349D0 (en) | 1998-05-02 | 1998-07-01 | Zeneca Ltd | Heterocyclic derivatives |
GB9902989D0 (en) | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Heterocyclic derivatives |
DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
DE10105989A1 (de) | 2001-02-09 | 2002-08-14 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
US7365205B2 (en) | 2001-06-20 | 2008-04-29 | Daiichi Sankyo Company, Limited | Diamine derivatives |
DE10129725A1 (de) | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
DE10134482A1 (de) | 2001-07-16 | 2003-01-30 | Bayer Ag | Substituierte Isoindole und ihre Verwendung |
DE10137163A1 (de) | 2001-07-30 | 2003-02-13 | Bayer Ag | Substituierte Isoindole und ihre Verwendung |
AU2003302238A1 (en) | 2002-12-03 | 2004-06-23 | Axys Pharmaceuticals, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
DE10300111A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
EP1685841A1 (de) | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prophylaxe und Behandlung von thrombolischen Erkrankungen |
DE102005045518A1 (de) * | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
DE102005047558A1 (de) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen |
EP1934208B1 (de) | 2005-10-04 | 2011-03-23 | Bayer Schering Pharma Aktiengesellschaft | Neue polymorphe form von 5-chlor-n-({ ( 5s )-2-0x0-3-[4-( 3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl} -methyl)-2-thiophencarboxamid |
DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
GB0813144D0 (en) | 2008-07-17 | 2008-08-27 | Glaxo Group Ltd | Novel compounds |
GB0813142D0 (en) | 2008-07-17 | 2008-08-27 | Glaxo Group Ltd | Novel compounds |
AU2020300002A1 (en) | 2019-07-01 | 2022-02-24 | Tonix Pharma Limited | Anti-CD154 antibodies and uses thereof |
JP2024503625A (ja) | 2021-01-06 | 2024-01-26 | トニックス ファーマ リミテッド | 改変された抗cd154抗体により免疫寛容を誘導する方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8905526D0 (en) * | 1989-03-10 | 1989-04-19 | Fujisawa Pharmaceutical Co | N-containing heterocyclic compounds,processes for the preparation thereof and composition comprising the same |
US5541330A (en) * | 1991-12-10 | 1996-07-30 | Eastman Kodak Company | Ion-sensitive compounds |
IL115420A0 (en) * | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
GB9602166D0 (en) * | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
UA56197C2 (uk) * | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
-
1997
- 1997-07-29 GB GBGB9715894.3A patent/GB9715894D0/en active Pending
-
1998
- 1998-07-23 NZ NZ501778A patent/NZ501778A/en unknown
- 1998-07-23 TR TR2000/00223T patent/TR200000223T2/xx unknown
- 1998-07-23 RU RU2000104829/04A patent/RU2225404C2/ru not_active IP Right Cessation
- 1998-07-23 ES ES98935208T patent/ES2219894T3/es not_active Expired - Lifetime
- 1998-07-23 CN CN98807641A patent/CN1265098A/zh active Pending
- 1998-07-23 EP EP98935208A patent/EP1000033B1/de not_active Expired - Lifetime
- 1998-07-23 US US09/463,625 patent/US6458793B1/en not_active Expired - Fee Related
- 1998-07-23 EP EP03018010A patent/EP1367054A1/de not_active Withdrawn
- 1998-07-23 BR BR9811055-1A patent/BR9811055A/pt not_active Application Discontinuation
- 1998-07-23 JP JP2000505130A patent/JP2001512103A/ja active Pending
- 1998-07-23 PT PT98935208T patent/PT1000033E/pt unknown
- 1998-07-23 PL PL98338355A patent/PL338355A1/xx not_active Application Discontinuation
- 1998-07-23 AU AU84557/98A patent/AU754747B2/en not_active Ceased
- 1998-07-23 IL IL13351698A patent/IL133516A0/xx unknown
- 1998-07-23 CA CA002295945A patent/CA2295945A1/en not_active Abandoned
- 1998-07-23 AT AT98935208T patent/ATE266007T1/de not_active IP Right Cessation
- 1998-07-23 DE DE69823665T patent/DE69823665T2/de not_active Expired - Lifetime
- 1998-07-23 KR KR1020007000678A patent/KR20010022108A/ko not_active Application Discontinuation
- 1998-07-23 SK SK127-2000A patent/SK1272000A3/sk unknown
- 1998-07-23 HU HU0002528A patent/HUP0002528A3/hu unknown
- 1998-07-23 DK DK98935208T patent/DK1000033T3/da active
- 1998-07-23 WO PCT/GB1998/002210 patent/WO1999006371A1/en not_active Application Discontinuation
-
2000
- 2000-01-28 NO NO20000448A patent/NO317419B1/no unknown
-
2002
- 2002-06-27 US US10/180,337 patent/US20020193375A1/en not_active Abandoned
-
2004
- 2004-02-05 NO NO20040520A patent/NO20040520L/no unknown
Also Published As
Publication number | Publication date |
---|---|
AU754747B2 (en) | 2002-11-21 |
EP1000033B1 (de) | 2004-05-06 |
PL338355A1 (en) | 2000-10-23 |
CN1265098A (zh) | 2000-08-30 |
BR9811055A (pt) | 2000-09-05 |
IL133516A0 (en) | 2001-04-30 |
GB9715894D0 (en) | 1997-10-01 |
US20020193375A1 (en) | 2002-12-19 |
DE69823665T2 (de) | 2005-04-28 |
RU2225404C2 (ru) | 2004-03-10 |
CA2295945A1 (en) | 1999-02-11 |
HUP0002528A2 (hu) | 2001-06-28 |
SK1272000A3 (en) | 2000-06-12 |
AU8455798A (en) | 1999-02-22 |
KR20010022108A (ko) | 2001-03-15 |
NO20040520L (no) | 2004-02-05 |
US6458793B1 (en) | 2002-10-01 |
ES2219894T3 (es) | 2004-12-01 |
PT1000033E (pt) | 2004-08-31 |
NO20000448D0 (no) | 2000-01-28 |
EP1000033A1 (de) | 2000-05-17 |
DK1000033T3 (da) | 2004-08-02 |
TR200000223T2 (tr) | 2000-07-21 |
ATE266007T1 (de) | 2004-05-15 |
EP1367054A1 (de) | 2003-12-03 |
NO317419B1 (no) | 2004-10-25 |
NZ501778A (en) | 2001-09-28 |
JP2001512103A (ja) | 2001-08-21 |
NO20000448L (no) | 2000-03-16 |
HUP0002528A3 (en) | 2002-09-30 |
WO1999006371A1 (en) | 1999-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE266007T1 (de) | Heterocyclische verbindungen als faktor xa inhibitoren | |
DK0937048T3 (da) | Heterocykliske derivater, der inhiberer faktor Xa | |
ATE282610T1 (de) | Heterozyklische verbindungen mit faktor xa hemmender wirkung | |
ATE245152T1 (de) | Dioxocyclopentylhydroxamsäure | |
DE69923444D1 (de) | Heterozyklische verbindungen mit faktor xa hemmender wirkung | |
PT992509E (pt) | Novos derivados macrolidos | |
PT1015449E (pt) | Derivados de (hetero)aril-sulfonamida, sua preparacao e sua utilizacao como inibidores do factor xa | |
DE60000410D1 (de) | Heterocyclische derivate als inhibitoren von faktor xa | |
ATE243219T1 (de) | 9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |